Brief: Ocuphire Pharma Announces Appointment Of George Magrath,

Opus Genetics

01/11/2023 12:07

Nov 1 (Reuters) - Ocuphire Pharma Inc  OCUP.O :
    * OCUPHIRE PHARMA ANNOUNCES APPOINTMENT OF GEORGE MAGRATH,
M.D.,
M.B.A., M.S., AS CHIEF EXECUTIVE OFFICER AND DIRECTOR
    * OCUPHIRE PHARMA INC -  MAGRATH SUCCEEDS RICK RODGERS
INTERIM
CHIEF EXECUTIVE OFFICER AND PRESIDENT SINCE APRIL 2023
    * OCUPHIRE PHARMA INC - RODGERS WILL REMAIN ON COMPANY'S
BOARD OF
DIRECTORS
    * OCUPHIRE PHARMA INC: APPOINTMENT OF GEORGE MAGRATH, M.D.,
M.B.A., M.S., AS CHIEF EXECUTIVE OFFICER AND MEMBER OF BOARD OF
DIRECTORS, EFFECTIVE TODAY.

Source text for Eikon:  ID:nGNX9lHDtw 
Further company coverage:  OCUP.O 

 ((Reuters.Briefs@thomsonreuters.com;))